Biofourmis announces major agreements with top pharmaceutical companies
Digital Health Global
FEBRUARY 19, 2024
Centered on digital biomarker and safety monitoring algorithm development, with a specific emphasis on cytokine release syndrome (CRS) detection, the oncology programs harness cutting-edge data science and technology to elevate remote data collection, patient monitoring, and safety protocols. Full press release here
Let's personalize your content